• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对完全化学稳定的小干扰RNA中七种主链和核糖修饰的位点特异性耐受性的系统评估

Systematic Evaluation of Position-Specific Tolerability of Seven Backbone and Ribose Modifications in Fully Chemically Stabilized siRNAs.

作者信息

O'Reilly Daniel, Furgal Raymond, Hariharan Vignesh, Lochmann Clemens, Cooper David, Echeverria Dimas, Khvorova Anastasia

机构信息

RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.

出版信息

Nucleic Acid Ther. 2025 Jun;35(3):137-149. doi: 10.1089/nat.2024.0077. Epub 2025 May 26.

DOI:10.1089/nat.2024.0077
PMID:40418189
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12167845/
Abstract

Chemically modified short interfering RNAs (siRNAs) unequivocally represent a groundbreaking class of drugs. The deliberate chemical modification of the natural structure has been pivotal to their resounding success. Specific modifications at certain positions bolster their potency, safety, stability, and specificity. In clinical research, 2'--methyl and 2'-fluoro are the most used modifications. The effects of a wide range of chemical changes in fully modified siRNAs have not been thoroughly evaluated for tolerability. In this study, we utilized two sequences in a fully modified siRNA to systematically assess the tolerability of single nucleotide backbone and sugar modifications, including deoxyribonucleic acid, 2'--(2-methoxyethyl), locked nucleic acid, unlocked nucleic acid, mismatches, butane diol substitution, and butane diol insertion. We synthesized 522 siRNA variants and evaluated their efficacy . Our findings demonstrate that individual tolerability is significantly influenced by the modification's sequence, pattern, and position, with limited universal principles identifiable from this dataset. The efficacy results are probably driven by the thermodynamic balance defined by a combination of parameters. The framework presented here will serve as a reference dataset to facilitate the expansion of chemical diversity in therapeutic siRNAs.

摘要

化学修饰的小干扰RNA(siRNA)无疑代表了一类开创性的药物。对其天然结构进行刻意的化学修饰对它们的巨大成功起到了关键作用。在某些位置进行特定修饰可增强其效力、安全性、稳定性和特异性。在临床研究中,2'-O-甲基和2'-氟是最常用的修饰。对于完全修饰的siRNA中广泛的化学变化对耐受性的影响尚未进行全面评估。在本研究中,我们在完全修饰的siRNA中使用两个序列,系统地评估单核苷酸主链和糖修饰的耐受性,包括脱氧核糖核酸、2'-O-(2-甲氧基乙基)、锁核酸、非锁核酸、错配、丁二醇取代和丁二醇插入。我们合成了522种siRNA变体并评估了它们的效力。我们的研究结果表明,个体耐受性受到修饰的序列、模式和位置的显著影响,从该数据集中可识别的通用原则有限。效力结果可能由多种参数组合定义的热力学平衡驱动。这里提出的框架将作为一个参考数据集,以促进治疗性siRNA化学多样性的扩展。

相似文献

1
Systematic Evaluation of Position-Specific Tolerability of Seven Backbone and Ribose Modifications in Fully Chemically Stabilized siRNAs.对完全化学稳定的小干扰RNA中七种主链和核糖修饰的位点特异性耐受性的系统评估
Nucleic Acid Ther. 2025 Jun;35(3):137-149. doi: 10.1089/nat.2024.0077. Epub 2025 May 26.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
3
Nucleic Acid Nanocapsules as a New Platform to Deliver Therapeutic Nucleic Acids for Gene Regulation.核酸纳米胶囊作为用于基因调控的治疗性核酸递送新平台。
Acc Chem Res. 2025 Jul 1;58(13):1951-1962. doi: 10.1021/acs.accounts.5c00126. Epub 2025 Jun 9.
4
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂(GLP-1 RAs)减肥效果的网状Meta分析的数量、质量及结果:一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
6
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
7
Development of a Gryllus bimaculatus-Based Assay System for Evaluating Chemically Modified siRNAs.基于双斑蟋蟀的化学修饰小干扰RNA评估检测系统的开发。
Biol Pharm Bull. 2025;48(6):941-950. doi: 10.1248/bpb.b25-00289.
8
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
9
Systematic analysis of siRNA and mRNA features impacting fully chemically modified siRNA efficacy.影响完全化学修饰的小干扰RNA(siRNA)功效的siRNA和信使核糖核酸(mRNA)特征的系统分析
Nucleic Acids Res. 2025 Jun 20;53(12). doi: 10.1093/nar/gkaf479.
10
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.纤维素、改性纤维素和合成膜在终末期肾病患者血液透析中的比较。
Cochrane Database Syst Rev. 2001(3):CD003234. doi: 10.1002/14651858.CD003234.

本文引用的文献

1
Chemistry, structure and function of approved oligonucleotide therapeutics.已获批的寡核苷酸治疗药物的化学、结构和功能。
Nucleic Acids Res. 2023 Apr 11;51(6):2529-2573. doi: 10.1093/nar/gkad067.
2
Recent progress in non-native nucleic acid modifications.非天然核酸修饰的最新进展。
Chem Soc Rev. 2021 Apr 26;50(8):5126-5164. doi: 10.1039/d0cs01430c.
3
Single-Stranded Phosphorothioated Regions Enhance Cellular Uptake of Cholesterol-Conjugated siRNA but Not Silencing Efficacy.单链硫代磷酸化区域增强胆固醇偶联小干扰RNA的细胞摄取,但不增强沉默效果。
Mol Ther Nucleic Acids. 2020 Sep 4;21:991-1005. doi: 10.1016/j.omtn.2020.07.029. Epub 2020 Jul 25.
4
Therapeutic siRNA: state of the art.治疗性 siRNA:最新进展。
Signal Transduct Target Ther. 2020 Jun 19;5(1):101. doi: 10.1038/s41392-020-0207-x.
5
High-Throughput Analysis Reveals Rules for Target RNA Binding and Cleavage by AGO2.高通量分析揭示了 AGO2 对靶 RNA 结合和切割的规则。
Mol Cell. 2019 Aug 22;75(4):741-755.e11. doi: 10.1016/j.molcel.2019.06.012. Epub 2019 Jul 16.
6
Current Development of siRNA Bioconjugates: From Research to the Clinic.小干扰RNA生物偶联物的当前发展:从研究到临床
Front Pharmacol. 2019 Apr 26;10:444. doi: 10.3389/fphar.2019.00444. eCollection 2019.
7
Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates.GalNAc-siRNA 缀合物的高级 siRNA 设计可进一步改善体内性能。
Mol Ther. 2018 Mar 7;26(3):708-717. doi: 10.1016/j.ymthe.2017.12.021. Epub 2018 Jan 4.
8
Chemical Modification of the siRNA Seed Region Suppresses Off-Target Effects by Steric Hindrance to Base-Pairing with Targets.小干扰RNA种子区域的化学修饰通过空间位阻抑制与靶标的碱基配对来减少脱靶效应。
ACS Omega. 2017 May 31;2(5):2055-2064. doi: 10.1021/acsomega.7b00291. Epub 2017 May 12.
9
Comparison of partially and fully chemically-modified siRNA in conjugate-mediated delivery in vivo.部分和完全化学修饰的 siRNA 在体内共轭介导传递中的比较。
Nucleic Acids Res. 2018 Mar 16;46(5):2185-2196. doi: 10.1093/nar/gky037.
10
Facile Synthesis, Geometry, and 2'-Substituent-Dependent in Vivo Activity of 5'-(E)- and 5'-(Z)-Vinylphosphonate-Modified siRNA Conjugates.5'-(E)-和 5'-(Z)-乙烯基膦酸酯修饰的 siRNA 缀合物的简便合成、几何形状和 2'-取代基依赖性体内活性。
J Med Chem. 2018 Feb 8;61(3):734-744. doi: 10.1021/acs.jmedchem.7b01147. Epub 2018 Jan 27.